Literature DB >> 10620102

Systemic AL amyloidosis in Gaucher disease. A case report and review of the literature.

A Kaloterakis1, A Filiotou, J Koskinas, I Raptis, C Zouboulis, H Michelakakis, S Hadziyannis.   

Abstract

Chronic Gaucher disease [GD] in association with systemic AL amyloidosis is extremely rare. We describe a 46-year-old Greek male with chronic GD confirmed by low glucocerebroside activity in fibroblasts and N370S/L444P mutations at the cerebrosidase gene, who also had systemic AL amyloidosis diagnosed by bone marrow diffuse plasmacytosis, serum monoclonal IgA-lambda, severe total proteinuria with monoclonal IgA-lambda, Bence-Jones-lambda and amyloid deposits in bone marrow, liver, spleen and kidney biopsy specimens. Treatment with melphalan and prednizolon has dramatically decreased both levels of serum M-IgA and proteinuria and also improved the clinical symptoms of amyloidosis. He died from restrictive cardiac disease 30 months after the diagnosis of amyloidosis. Previously reported cases of GD in association with AL amyloidosis are reviewed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10620102     DOI: 10.1046/j.1365-2796.1999.00607.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

1.  Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.

Authors:  Hiroki Mizukami; Yide Mi; Ryuichi Wada; Mari Kono; Tadashi Yamashita; Yujing Liu; Norbert Werth; Roger Sandhoff; Konrad Sandhoff; Richard L Proia
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.

Authors:  T M Cox; J M F G Aerts; N Belmatoug; M D Cappellini; S vom Dahl; J Goldblatt; G A Grabowski; C E M Hollak; P Hwu; M Maas; A M Martins; P K Mistry; G M Pastores; A Tylki-Szymanska; J Yee; N Weinreb
Journal:  J Inherit Metab Dis       Date:  2008-05-23       Impact factor: 4.982

Review 3.  Immunological cells and functions in Gaucher disease.

Authors:  Manoj Kumar Pandey; Gregory A Grabowski
Journal:  Crit Rev Oncog       Date:  2013

Review 4.  'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature.

Authors:  M Biegstraaten; I N van Schaik; J M F G Aerts; C E M Hollak
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.750

5.  Gaucher disease and cancer: concept and controversy.

Authors:  Francis Y M Choy; Tessa N Campbell
Journal:  Int J Cell Biol       Date:  2011-06-07

Review 6.  Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement.

Authors:  Andrew J Degnan; Victor M Ho-Fung; Rebecca C Ahrens-Nicklas; Christian A Barrera; Suraj D Serai; Dah-Jyuu Wang; Can Ficicioglu
Journal:  Insights Imaging       Date:  2019-07-10

7.  Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature.

Authors:  M de Fost; T A Out; F A de Wilde; E P M Tjin; S T Pals; M H J van Oers; R G Boot; J F M G Aerts; M Maas; S Vom Dahl; C E M Hollak
Journal:  Ann Hematol       Date:  2008-02-15       Impact factor: 3.673

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.